mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-08 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-08 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-08 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-08 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.39 |
5e-08 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-08 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-08 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
1e-07 |
mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
3e-07 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |